Skip to main content

Peer Review reports

From: Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks

Original Submission
10 Jul 2023 Submitted Original manuscript
14 Sep 2023 Reviewed Reviewer Report
24 Nov 2023 Reviewed Reviewer Report
14 Jan 2024 Author responded Author comments - Frank Mulindwa
Resubmission - Version 2
14 Jan 2024 Submitted Manuscript version 2
17 Jan 2024 Author responded Author comments - Frank Mulindwa
Resubmission - Version 3
17 Jan 2024 Submitted Manuscript version 3
18 Jan 2024 Author responded Author comments - Frank Mulindwa
Resubmission - Version 4
18 Jan 2024 Submitted Manuscript version 4
16 May 2024 Reviewed Reviewer Report
30 Jun 2024 Author responded Author comments - Frank Mulindwa
Resubmission - Version 5
30 Jun 2024 Submitted Manuscript version 5
4 Jul 2024 Author responded Author comments - Frank Mulindwa
Resubmission - Version 6
4 Jul 2024 Submitted Manuscript version 6
11 Jul 2024 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
23 Jul 2024 Editorially accepted
29 Jul 2024 Article published 10.1186/s12879-024-09655-9

You can find further information about peer review here.

Back to article page